troleandomycin has been researched along with aminopyrine in 4 studies
Studies (troleandomycin) | Trials (troleandomycin) | Recent Studies (post-2010) (troleandomycin) | Studies (aminopyrine) | Trials (aminopyrine) | Recent Studies (post-2010) (aminopyrine) |
---|---|---|---|---|---|
569 | 26 | 23 | 4,320 | 130 | 72 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chen, JH; Ding, H; Kong, R; Li, QX; Peng, RX; Wang, H; Yu, JP; Zhang, YH | 1 |
Laczay, P; Monostory, K; Szucs, G; Tamási, V | 1 |
4 other study(ies) available for troleandomycin and aminopyrine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Demethylation capacity of human fetal adrenal mitochondrial cytochrome P-450 in vitro.
Topics: Adrenal Glands; Aminopyrine; Benzphetamine; Cytochrome P-450 Enzyme System; Erythromycin; Fetus; Formaldehyde; Humans; Microsomes, Liver; Mitochondria; Troleandomycin | 1999 |
Biochemical background of toxic interaction between tiamulin and monensin.
Topics: Administration, Oral; Aminopyrine; Animals; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP3A; Dexamethasone; Diterpenes; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Induction; Ethylmorphine; Female; Ionophores; Male; Microsomes, Liver; Monensin; Oxidoreductases, N-Demethylating; Phenobarbital; Rats; Troleandomycin | 2004 |